Efficacy and Safety of Insulin RinGlar ® Compared to Lantus® SoloStar® in Type 1 Diabetes Mellitus Patients

Conditions:   Diabetes Mellitus, Type 1;   Diabetes Mellitus Interventions:   Drug: Lantus Solostar, 100 Units/mL Subcutaneous Solution;   Drug: Insulin RinGlar, 100 Units/mL Subcutaneous Solution Sponsor:   Geropharm Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials